The Evolution of Complex Muscle Cell In Vitro Models to Study Pathomechanisms and Drug Development of Neuromuscular Disease
2022 | journal article; overview. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
The Evolution of Complex Muscle Cell In Vitro Models to Study Pathomechanisms and Drug Development of Neuromuscular Disease
Zschüntzsch, J.; Meyer, S.; Shahriyari, M.; Kummer, K.; Schmidt, M.; Kummer, S. & Tiburcy, M. (2022)
Cells, 11(7) pp. 1233. DOI: https://doi.org/10.3390/cells11071233
Documents & Media
Details
- Authors
- Zschüntzsch, Jana; Meyer, Stefanie; Shahriyari, Mina; Kummer, Karsten; Schmidt, Matthias; Kummer, Susann; Tiburcy, Malte
- Abstract
- Many neuromuscular disease entities possess a significant disease burden and therapeutic options remain limited. Innovative human preclinical models may help to uncover relevant disease mechanisms and enhance the translation of therapeutic findings to strengthen neuromuscular disease precision medicine. By concentrating on idiopathic inflammatory muscle disorders, we summarize the recent evolution of the novel in vitro models to study disease mechanisms and therapeutic strategies. A particular focus is laid on the integration and simulation of multicellular interactions of muscle tissue in disease phenotypes in vitro. Finally, the requirements of a neuromuscular disease drug development workflow are discussed with a particular emphasis on cell sources, co-culture systems (including organoids), functionality, and throughput.
- Issue Date
- 2022
- Journal
- Cells
- Project
- SFB 1002: Modulatorische Einheiten bei Herzinsuffizienz
SFB 1002 | C04: Fibroblasten-Kardiomyozyten Interaktion im gesunden und erkrankten Herzen: Mechanismen und therapeutische Interventionen bei Kardiofibroblastopathien - Working Group
- RG Tiburcy (Stem Cell Disease Modeling)
- eISSN
- 2073-4409
- Language
- English
- Sponsor
- Open-Access-Publikationsfonds 2022